BAM
Blueshift Asset Management’s Integra LifeSciences IART Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $226K | Buy |
+18,435
| New | +$226K | 0.07% | 363 |
|
|
2022
Q2 | – | Sell |
-10,106
| Closed | -$649K | – | 827 |
|
|
2022
Q1 | $649K | Buy |
+10,106
| New | +$649K | 0.06% | 357 |
|
|
2021
Q3 | – | Sell |
-8,803
| Closed | -$601K | – | 1133 |
|
|
2021
Q2 | $601K | Buy |
+8,803
| New | +$601K | 0.03% | 509 |
|
|
2020
Q1 | – | Sell |
-5,633
| Closed | -$328K | – | 426 |
|
|
2019
Q4 | $328K | Buy |
+5,633
| New | +$328K | 0.04% | 579 |
|
|
2019
Q1 | – | Sell |
-5,096
| Closed | -$230K | – | 821 |
|
|
2018
Q4 | $230K | Buy |
+5,096
| New | +$230K | 0.04% | 548 |
|